12.1 C
London

Tom Harrington

Westminster correspondent

AI-Powered Commerce Toolkit: Vertiqal Studios and Revmo Redefine Brand Strategy on Social Media

A Strategic Shift in Digital Advertising The AI-Powered Commerce Toolkit, the latest innovation from Vertiqal Studios in collaboration with data intelligence firm Revmo, could soon become a cornerstone of modern digital strategy. With the rise of social commerce, this proprietary...

VitaGuard™ Strategic Alliance Revolutionizes Precision Oncology in Southeast Asia

VitaGuard™ Precision Oncology partnership ushers in a breakthrough in cancer diagnostics. BioNexus Gene Lab Corp. has entered a strategic cross‑equity alliance with Singapore’s Fidelion Diagnostics to commercialise VitaGuard™ across ASEAN. VitaGuard™ Precision Oncology Alliance: A Landmark Deal BGLC will acquire a...

Sidus Space Public Offering – Strategic Capital Raise Amid High-Stakes Growth Agenda

The Sidus Space Public Offering has been priced at $1.05 per share, with the company aiming to raise $7.5 million in gross proceeds. This latest capital move underscores Sidus Space’s ambition to scale its space-based infrastructure capabilities amid an...

Faraday Future Partners with HabitTrade to Enter Web3 Financial Ecosystem

Faraday Future Partners with HabitTrade marks a strategic entry into the Web3 financial ecosystem for Faraday Future. This collaboration establishes a robust foundation for the company’s expansion beyond electric mobility into digital finance. Strategic Collaboration Faraday Future has formed a strategic...

Invest in Gold During Economic Uncertainty: Is the Safe Haven Still Worth It?

Why Invest in Gold During Economic Uncertainty? Invest in gold during economic uncertainty remains one of the most common strategies for safeguarding wealth. Gold has long been seen as a reliable hedge when financial markets become volatile. Its enduring appeal...

THC Therapeutics Acquisition of SugarTop Buddery Reinforces Strategic National Expansion

THC Therapeutics Acquisition of SugarTop Buddery has been confirmed in an all-share transaction valued at approximately $3 million, entirely settled through newly issued Series D Preferred stock. This strategic acquisition further strengthens THC Therapeutics, Inc. (OTC: THCT) as it...
spot_img

latest articles